Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.
Copyright 2020 NPR
Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.
Copyright 2020 NPR